Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma

医学 微波消融 回顾性队列研究 外科 放射科 烧蚀 内科学
作者
Lin Yan,Ying Liu,Wenhui Li,Zhu Ya-lin,Jinling Wang,Mingbo Zhang,Jie Tang,Ying Che,Hui Wang,Shu‐Rong Wang,Yukun Luo
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:277 (5): 846-853 被引量:14
标识
DOI:10.1097/sla.0000000000005800
摘要

To report more than 5-year outcomes of ultrasound-guided thermal ablation (TA) for patients with solitary low-risk papillary thyroid microcarcinoma (PTMC) in a large multicenter cohort.TA, including radiofrequency ablation (RFA) and microwave ablation (MWA) have been used in patients with low-risk PTMC who refuse surgery or active surveillance. However, its clinical value remains controversial.This retrospective multicenter study included 474 patients with solitary low-risk PTMC treated with TA (357 for RFA; 117 for MWA) from 4 centers and followed up for at least 5 years. Disease progression including lymph node metastasis and recurrent tumors, volume reduction rate (VRR), tumor disappearance rate, complications, and delayed surgery were assessed. RFA and MWA outcomes were compared using propensity score matching.During the median follow-up period of 77.2 months, disease progression incidence, lymph node metastasis, and recurrent tumors rates were 3.6%, 1.1%, and 2.5%, respectively. Age below 40 years old, male sex, Hashimoto thyroiditis, and tumor size were not independent factors associated with disease progression by Cox analysis. The median VRR was 100% and 471 tumors disappeared radiographically. Eight patients experienced transient voice change (1.7%) which recovered within 3 months. None of the patients underwent delayed surgery because of anxiety. After 1:1 matching, no significant differences were found in the disease progression, VRR, tumor disappearance rate, or complications between RFA and MWA subgroups.This multicenter study revealed that TA was an effective and safe treatment for patients with solitary low-risk PTMC, which could be offered as a treatment option for the management for low-risk PTMC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
婉莹完成签到 ,获得积分0
刚刚
onevip完成签到,获得积分10
2秒前
3秒前
冷酷的乐驹完成签到 ,获得积分10
6秒前
飞云完成签到 ,获得积分10
12秒前
18秒前
steph发布了新的文献求助10
20秒前
忐忑的雪糕完成签到 ,获得积分10
23秒前
不安的晓灵完成签到 ,获得积分10
24秒前
梓泽丘墟完成签到,获得积分10
24秒前
27秒前
moon完成签到 ,获得积分10
28秒前
一叶飘红完成签到,获得积分10
32秒前
烟雨醉巷完成签到 ,获得积分10
32秒前
33秒前
Hululu完成签到 ,获得积分10
33秒前
momo完成签到 ,获得积分10
34秒前
NN完成签到,获得积分10
36秒前
易玉燕应助科研通管家采纳,获得10
38秒前
科研通AI2S应助科研通管家采纳,获得10
38秒前
江湖完成签到 ,获得积分10
49秒前
冷静长颈鹿完成签到 ,获得积分10
50秒前
CY完成签到,获得积分10
51秒前
51秒前
周全完成签到 ,获得积分10
54秒前
我不会乱起名字的完成签到,获得积分10
1分钟前
徐徐徐徐完成签到 ,获得积分10
1分钟前
诗蕊完成签到 ,获得积分0
1分钟前
zhangjw完成签到 ,获得积分10
1分钟前
刻苦的新烟完成签到 ,获得积分10
1分钟前
姜姜完成签到 ,获得积分10
1分钟前
英喆完成签到 ,获得积分10
1分钟前
文欣完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
闪闪的荔枝完成签到 ,获得积分10
1分钟前
hmhu发布了新的文献求助10
1分钟前
wangqiang发布了新的文献求助10
1分钟前
shimenwanzhao完成签到 ,获得积分0
1分钟前
simpleblue完成签到 ,获得积分10
1分钟前
高分求助中
The ACS Guide to Scholarly Communication 2500
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Achieving 99% link uptime on a fleet of 100G space laser inter-satellite links in LEO 1000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Ethnicities: Media, Health, and Coping 700
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3090976
求助须知:如何正确求助?哪些是违规求助? 2743310
关于积分的说明 7573036
捐赠科研通 2393995
什么是DOI,文献DOI怎么找? 1269590
科研通“疑难数据库(出版商)”最低求助积分说明 614351
版权声明 598756